Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial

Title
Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
Authors
Keywords
Propolis, Anti-inflammatory agents, Immunoregulation, ACE2, PAK1 blocker, TMPRSS2
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 138, Issue -, Pages 111526
Publisher
Elsevier BV
Online
2021-03-21
DOI
10.1016/j.biopha.2021.111526

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More